What is AstraZeneca PLC's Market Cap?

AstraZeneca PLC's Market Cap is $510.2B, based on as-reported figures from SEC (XBRL) filings.

What is AstraZeneca PLC's Enterprise Value?

AstraZeneca PLC's Enterprise Value is $281.8B, based on as-reported figures from SEC (XBRL) filings.

What is AstraZeneca PLC's Trailing P/E?

AstraZeneca PLC's Trailing P/E is 49.9×, based on as-reported figures from SEC (XBRL) filings.

What is AstraZeneca PLC's Price / Sales?

AstraZeneca PLC's Price / Sales is 8.7×, based on as-reported figures from SEC (XBRL) filings.

What is AstraZeneca PLC's EV / Revenue?

AstraZeneca PLC's EV / Revenue is 4.8×, based on as-reported figures from SEC (XBRL) filings.

What is AstraZeneca PLC's Revenue (TTM)?

AstraZeneca PLC's Revenue (TTM) is $58.7B, based on as-reported figures from SEC (XBRL) filings.

What is AstraZeneca PLC's Net Income (TTM)?

AstraZeneca PLC's Net Income (TTM) is $10.2B, based on as-reported figures from SEC (XBRL) filings.

What is AstraZeneca PLC's Diluted EPS (TTM)?

AstraZeneca PLC's Diluted EPS (TTM) is 3.30, based on as-reported figures from SEC (XBRL) filings.

What is AstraZeneca PLC's Net Debt?

AstraZeneca PLC's Net Debt is $19.0B, based on as-reported figures from SEC (XBRL) filings.

AstraZeneca PLC (AZN) Financial Statements

AstraZeneca PLC

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SB80N8

XNYS · usd

164.50▼ 4.97 (-2.93%)

As of 2026-07-14

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA—

Financial Highlights

Revenue (TTM)$58.7B

Net Income (TTM)$10.2B

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close169.47

Day's Range164.45 – 168.10

52-Week Range68.62 – 212.71

Volume3.31M

Avg Volume2.39M

Share Statistics

Shares Outstanding3.1B

Employees96.1K

ExchangeXNYS

Listed2009-10-23

Key questions about AstraZeneca PLC (AZN)

What is AstraZeneca PLC's Market Cap?: AstraZeneca PLC's Market Cap is $510.2B, based on as-reported figures from SEC (XBRL) filings.
What is AstraZeneca PLC's Enterprise Value?: AstraZeneca PLC's Enterprise Value is $281.8B, based on as-reported figures from SEC (XBRL) filings.
What is AstraZeneca PLC's Trailing P/E?: AstraZeneca PLC's Trailing P/E is 49.9×, based on as-reported figures from SEC (XBRL) filings.
What is AstraZeneca PLC's Price / Sales?: AstraZeneca PLC's Price / Sales is 8.7×, based on as-reported figures from SEC (XBRL) filings.
What is AstraZeneca PLC's EV / Revenue?: AstraZeneca PLC's EV / Revenue is 4.8×, based on as-reported figures from SEC (XBRL) filings.
What is AstraZeneca PLC's Revenue (TTM)?: AstraZeneca PLC's Revenue (TTM) is $58.7B, based on as-reported figures from SEC (XBRL) filings.
What is AstraZeneca PLC's Net Income (TTM)?: AstraZeneca PLC's Net Income (TTM) is $10.2B, based on as-reported figures from SEC (XBRL) filings.
What is AstraZeneca PLC's Diluted EPS (TTM)?: AstraZeneca PLC's Diluted EPS (TTM) is 3.30, based on as-reported figures from SEC (XBRL) filings.
What is AstraZeneca PLC's Net Debt?: AstraZeneca PLC's Net Debt is $19.0B, based on as-reported figures from SEC (XBRL) filings.

View

Period

Loading Income Statement…